Biothera Revenue, Growth & Competitor Profile

DBA IMMUNO RESEARCH INC

Company Profile & Annual Report for Biothera

Access the complete profile.

Biothera Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	2535 Pilot Knob Rd Ste 105 Saint Paul, MN 55120

Note: Revenues for privately held companies are statistical evaluations.


Biothera's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Biothera's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Biothera is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Biothera Annual Revenue and Growth Rate

Biothera	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Biothera's revenues are gauged from an analysis of company filings.

Biothera's Income Statement (based on Industry Averages)

Biothera P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Biothera is developing and marketing. Biothera doesn't have any recent trademark applications, indicating Biothera is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
WELLMUDERM Carbohydrates sold as an integral component of medicated skin care preparations	04/02/2014
IMPRIME WGP Pharmaceuticals in the nature of immunotherapeutic agents and pharmaceutical preparations for modulating cells of the immune system, all of which contain whole glucan particles	05/28/2013
IMPRIME Pharmaceuticals in the nature of immunotherapeutic agents and pharmaceutical preparations for modulating cells of the immune system	10/26/2012

See all trademarks and details in the Full Report.

Market Share of Biothera's Largest Competitors

A competitive analysis shows these companies are in the same general field as Biothera, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Biothera. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BELL INTERNATIONAL LABORATORIES	Eagan, MN	100
ZEPTO LIFE TECHNOLOGY	Saint Paul, MN	13
NANOCOPOEIA	St Paul, MN	11
BIOTHERA PHARMACEUTICALS	Mendota Heights, MN	11
CEREBRAL THERAPEUTICS	Oakdale, MN	7
BIOTHERA	Saint Paul, MN	1

Future Competition: Biothera's Fastest Growing Competitors

These companies are in the same general field as Biothera and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)